Caris Life Sciences (CAI) Depreciation & Amortization (CF) (2024 - 2026)

Caris Life Sciences' Depreciation & Amortization (CF) history runs 3 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 27.61% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $20.7 million (down 45.96% YoY), while the FY2025 annual figure was $22.6 million, down 53.8% from the prior year.
• Depreciation & Amortization (CF) was $5.1 million for Q1 2026 at Caris Life Sciences, up from $4.3 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $11.6 million in Q2 2024 to a low of $4.3 million in Q4 2025.
• Historically, Depreciation & Amortization (CF) has averaged $7.4 million across 3 years, with a median of $6.7 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) plunged 53.33% in 2025, then slipped 27.61% in 2026.
• A 3-year view of Depreciation & Amortization (CF) shows it stood at $9.1 million in 2024, then slumped by 53.08% to $4.3 million in 2025, then gained by 19.27% to $5.1 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $5.1 million (Q1 2026), $4.3 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.